These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2752117)

  • 1. High-dose intravenous immunoglobulin modifies complement-mediated in vivo clearance.
    Basta M; Langlois PF; Marques M; Frank MM; Fries LF
    Blood; 1989 Jul; 74(1):326-33. PubMed ID: 2752117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High doses of intravenous Ig inhibit in vitro uptake of C4 fragments onto sensitized erythrocytes.
    Basta M; Fries LF; Frank MM
    Blood; 1991 Jan; 77(2):376-80. PubMed ID: 1985703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of therapeutic effect of high-dose intravenous immunoglobulin. Attenuation of acute, complement-dependent immune damage in a guinea pig model.
    Basta M; Kirshbom P; Frank MM; Fries LF
    J Clin Invest; 1989 Dec; 84(6):1974-81. PubMed ID: 2687331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia.
    Brown EJ; Hosea SW; Hammer CH; Burch CG; Frank MM
    J Clin Invest; 1982 Jan; 69(1):85-98. PubMed ID: 7054244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of antibody and complement in the immune clearance and destruction of erythrocytes. I. In vivo effects of IgG and IgM complement-fixing sites.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):575-82. PubMed ID: 4536807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of complement activity by immunoglobulin. I. Effect of immunoglobulin isotype on C4 uptake on antibody-sensitized sheep erythrocytes and solid phase immune complexes.
    Miletic VD; Hester CG; Frank MM
    J Immunol; 1996 Jan; 156(2):749-57. PubMed ID: 8543829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of desialated guinea pig erythrocytes with the classical and alternative pathways of guinea pig complement in vivo and in vitro.
    Brown EJ; Joiner KA; Frank MM
    J Clin Invest; 1983 Jun; 71(6):1710-9. PubMed ID: 6863540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose intravenous immunoglobulin treatment activates complement in vivo.
    Mollnes TE; Høgåsen K; De Carolis C; Vaquero E; Nielsen EW; Fontana L; Perricone R
    Scand J Immunol; 1998 Sep; 48(3):312-7. PubMed ID: 9743219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High doses of intravenous immunoglobulin do not affect the recognition phase of the classical complement pathway.
    Basta M; Fries LF; Frank MM
    Blood; 1991 Aug; 78(3):700-2. PubMed ID: 1859883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin prevents experimental autoimmune myositis in SJL mice by reducing anti-myosin antibody and by blocking complement deposition.
    Wada J; Shintani N; Kikutani K; Nakae T; Yamauchi T; Takechi K
    Clin Exp Immunol; 2001 May; 124(2):282-9. PubMed ID: 11422206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin M-enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammation.
    Rieben R; Roos A; Muizert Y; Tinguely C; Gerritsen AF; Daha MR
    Blood; 1999 Feb; 93(3):942-51. PubMed ID: 9920844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intravenous immunoglobulin (IVIg) on primate complement-dependent cytotoxicity of genetically engineered pig cells: relevance to clinical xenotransplantation.
    Yamamoto T; Cui Y; Patel D; Jagdale A; Iwase H; Ayares D; Cooper DKC; Hara H
    Sci Rep; 2020 Jul; 10(1):11747. PubMed ID: 32678137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of corticosteroids and splenectomy on the immune clearance and destruction of erythrocytes.
    Atkinson JP; Schreiber AD; Frank MM
    J Clin Invest; 1973 Jun; 52(6):1509-17. PubMed ID: 4703235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of complement-mediated immune damage by intravenous immune globulin.
    Basta M
    Clin Exp Immunol; 1996 May; 104 Suppl 1():21-5. PubMed ID: 8625538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of intravenous immune globulin on complement-dependent immune damage of cells and tissues.
    Frank MM; Basta M; Fries LF
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S82-6. PubMed ID: 1728991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing the endocytosis of immune complexes.
    van Es LA; Daha MR
    Adv Nephrol Necker Hosp; 1984; 13():341-67. PubMed ID: 6236677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement C3 deposition onto bacteria by neonatal serum is not enhanced after the infusion of intravenous immunoglobulin.
    Lassiter HA; Speranza MJ; Hall RT; Meade V; Christensen RD; Parker CJ
    J Perinatol; 1990 Mar; 10(1):27-31. PubMed ID: 2107285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of complement in the clearance of cold agglutinin-sensitized erythrocytes in man.
    Jaffe CJ; Atkinson JP; Frank MM
    J Clin Invest; 1976 Oct; 58(4):942-9. PubMed ID: 965497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The failure to show a necessary role for C3 in the in vitro antibody response.
    Waldmann H; Lachmann PJ
    Eur J Immunol; 1975 Mar; 5(3):185-93. PubMed ID: 1086224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.